About State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
During the past decade, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Sun Yat-sen University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
According to Clinical.Site data, the most researched conditions in "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center" are
"Breast Cancer" (5 trials), "Brain Metastases" (1 trials) and "Brain Metastasis" (1 trials). Many other conditions were trialed in "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
Most popular intervention types in "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aromatase Inhibitor" (2 trials), "Bicalutamide" (1 trials), "Capecitabine" (1 trials), "Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant" (1 trials) and "fulvestrant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
The vast majority of trials in "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center" are
5 trials for "Female" genders.
Clinical Trials Status at State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center
Currently, there are NaN active trials in "State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center".
1 are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".